Medtronic PLC $MDT Stock Bought by Lido Advisors LLC

Lido Advisors LLC boosted its stake in shares of Medtronic PLC (NYSE:MDT) by 28.8% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 99,829 shares of the medical technology company’s stock after acquiring an additional 22,351 shares during the quarter. Lido Advisors LLC’s holdings in Medtronic were worth $8,615,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Activest Wealth Management lifted its holdings in shares of Medtronic by 470.9% during the third quarter. Activest Wealth Management now owns 314 shares of the medical technology company’s stock worth $27,000 after purchasing an additional 259 shares during the period. IAG Wealth Partners LLC purchased a new position in Medtronic in the 2nd quarter valued at $30,000. Team Financial Group LLC purchased a new position in Medtronic in the 3rd quarter valued at $31,000. Avion Wealth grew its position in Medtronic by 97.8% in the 3rd quarter. Avion Wealth now owns 362 shares of the medical technology company’s stock valued at $31,000 after buying an additional 179 shares during the last quarter. Finally, Pin Oak Investment Advisors Inc. acquired a new position in Medtronic in the 2nd quarter valued at $32,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Medtronic

In other Medtronic news, EVP Harry Kiil sold 1,483 shares of Medtronic stock in a transaction that occurred on Wednesday, September 16th. The shares were sold at an average price of $93.65, for a total value of $138,882.95. Following the completion of the sale, the executive vice president directly owned 42,186 shares of the company’s stock, valued at approximately $3,950,718.90. The trade was a 3.40% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Michael Marinaro sold 10,420 shares of Medtronic stock in a transaction that occurred on Thursday, October 15th. The stock was sold at an average price of $96.00, for a total transaction of $1,000,320.00. Following the completion of the sale, the executive vice president directly owned 105,916 shares of the company’s stock, valued at $10,167,936. The trade was a 8.96% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 61,903 shares of company stock valued at $5,889,203. Company insiders own 0.27% of the company’s stock.

Wall Street Analyst Weigh In

MDT has been the subject of a number of analyst reports. Wall Street Zen upgraded shares of Medtronic from a “hold” rating to a “buy” rating in a research report on Sunday, November 8th. Royal Bank Of Canada restated an “outperform” rating and issued a $118.00 target price on shares of Medtronic in a research note on Wednesday, September 2nd. Wells Fargo & Company lifted their target price on shares of Medtronic from $102.00 to $104.00 and gave the company an “overweight” rating in a report on Wednesday, September 2nd. Needham & Company LLC reiterated a “buy” rating on shares of Medtronic in a research note on Thursday, September 17th. Finally, Deutsche Bank reiterated a “hold” rating and set a $92.00 price target on shares of Medtronic in a research note on Thursday, September 3rd. Eighteen analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $102.88.

Medtronic Stock Down 0.6%

Shares of NYSE MDT opened at $100.96 on Friday. The stock has a market capitalization of $129.14 billion, a price-to-earnings ratio of 24.87, a price-to-earnings-growth ratio of 2.38 and a beta of 0.56. Medtronic PLC has a 52 week low of $73.31 and a 52 week high of $106.33. The firm has a 50-day moving average price of $93.52 and a 200 day moving average price of $88.46. The company has a quick ratio of 1.54, a current ratio of 2.07 and a debt-to-equity ratio of 0.50.

Medtronic (NYSE:MDT) last released its quarterly earnings data on Tuesday, September 1st. The medical technology company reported $1.45 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.06. Medtronic had a return on equity of 14.78% and a net margin of 13.93%. The firm had revenue of $9.76 billion during the quarter, compared to the consensus estimate of $9.55 billion. During the same period last year, the business posted $1.26 EPS. Medtronic’s quarterly revenue was up 13.7% on a year-over-year basis. Medtronic has set its Q2 2027 guidance at 1.320-1.340 EPS and its FY 2027 guidance at 5.940-6.000 EPS. Equities research analysts anticipate that Medtronic PLC will post 5.98 EPS for the current fiscal year.

Medtronic Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 16th. Investors of record on Friday, September 25th were paid a dividend of $0.72 per share. The ex-dividend date of this dividend was Friday, September 25th. This represents a $2.88 annualized dividend and a dividend yield of 2.9%. Medtronic’s dividend payout ratio is presently 70.94%.

About Medtronic

Medtronic plc is a medical technology company that develops and manufactures devices and therapies for a range of health conditions. Its products include pacemakers and defibrillators, heart valves, surgical technologies, neurostimulation devices, and insulin pumps and other diabetes-management products. The company was founded in Minneapolis in 1949 by Earl Bakken and Palmer Hermundslie as a medical equipment repair business. It has since grown into a global company serving patients and health care providers in more than 150 countries.